DE60323938D1 - Verwendung von Estrogenen zur Behandlung von Männerunfruchtbarkeit - Google Patents

Verwendung von Estrogenen zur Behandlung von Männerunfruchtbarkeit

Info

Publication number
DE60323938D1
DE60323938D1 DE60323938T DE60323938T DE60323938D1 DE 60323938 D1 DE60323938 D1 DE 60323938D1 DE 60323938 T DE60323938 T DE 60323938T DE 60323938 T DE60323938 T DE 60323938T DE 60323938 D1 DE60323938 D1 DE 60323938D1
Authority
DE
Germany
Prior art keywords
estrogen
sperm
drug delivery
relates
male
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60323938T
Other languages
English (en)
Inventor
Jacob Jan Maas
Bennink Herman Jan Tijmen Coelingh
Eberhard Nieschlag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pantarhei Bioscience BV
Original Assignee
Pantarhei Bioscience BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantarhei Bioscience BV filed Critical Pantarhei Bioscience BV
Application granted granted Critical
Publication of DE60323938D1 publication Critical patent/DE60323938D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DE60323938T 2003-03-27 2003-03-27 Verwendung von Estrogenen zur Behandlung von Männerunfruchtbarkeit Expired - Lifetime DE60323938D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03075894A EP1468690B1 (de) 2003-03-27 2003-03-27 Verwendung von Estrogenen zur Behandlung von Männerunfruchtbarkeit

Publications (1)

Publication Number Publication Date
DE60323938D1 true DE60323938D1 (de) 2008-11-20

Family

ID=32892928

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60323938T Expired - Lifetime DE60323938D1 (de) 2003-03-27 2003-03-27 Verwendung von Estrogenen zur Behandlung von Männerunfruchtbarkeit

Country Status (4)

Country Link
EP (1) EP1468690B1 (de)
AT (1) ATE410170T1 (de)
DE (1) DE60323938D1 (de)
ES (1) ES2315455T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2179741B1 (de) 2005-08-26 2014-10-15 The Board Of Trustees Of The Leland Stanford Junior University Verfahren zur behandlung von kopfschmerzen durch verabreichung von oxytocin
FI3242676T3 (fi) 2015-01-07 2023-11-07 TONIX Pharmaceuticals Holding Corp Magnesiumipitoisia oksitosiiniformulaatioita ja käyttömenetelmiä
CA3042032A1 (en) 2016-10-26 2018-05-03 Revive Pharmaceuticals, Llc Treating sexual dysfunction
US20210145815A1 (en) * 2017-09-22 2021-05-20 The University Of Adelaide Methods and products for improving sperm quality
CN110169377B (zh) * 2019-06-27 2021-09-14 浙江海洋大学 黄姑鱼的人工催产受精方法
CN112999330B (zh) * 2021-03-18 2023-04-18 成都大学 苯甲酸雌二醇与缩宫素长效混悬注射液的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701161D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use I
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
SE9803272D0 (sv) * 1998-09-25 1998-09-25 Kerstin Uvnaes Moberg A drug for cell regeneration
DE19917930A1 (de) * 1999-04-15 2000-10-19 Schering Ag Ent-Steroide als selektiv wirksame Estrogene
EP1272505B1 (de) * 2000-04-12 2005-08-24 Schering Aktiengesellschaft 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate

Also Published As

Publication number Publication date
ES2315455T3 (es) 2009-04-01
EP1468690A1 (de) 2004-10-20
ATE410170T1 (de) 2008-10-15
EP1468690B1 (de) 2008-10-08

Similar Documents

Publication Publication Date Title
Freitas et al. Estrus synchronization in dairy goats: use of fluorogestone acetate vaginal sponges or norgestomet ear implants
AP2001002129A0 (en) 5HT1 receptor agonists and metoclopramide for the treatment of migrane.
ZA200108443B (en) Methods for assessing, improving, or maintaining urogenital health in postmenopausal women.
BG100766A (en) Treatment of ovarian estrogen dependent conditions
HK1113971A1 (en) Oral formulations for delivery of catecholic butanes including ndga compounds
HUP0103078A2 (hu) Készítmények és eljárások szürkehályog kezelésére
DE60323938D1 (de) Verwendung von Estrogenen zur Behandlung von Männerunfruchtbarkeit
AU2002311556A1 (en) Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease
DE69911023D1 (de) Antagonisten des gonadotropin freisetzenden hormons
ATE412412T1 (de) Derivate des 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1 -pyrazols als antagonisten des gonadotropin freisetzenden hormons (gnrh) zur anwendung in de behandlung von geschlechtshormonellen erkrankungen, wie prostata-oder gebahrmutterkrebs
BR0103913A (pt) Tratamento de combinação para depressão e ansiedade
ATE266981T1 (de) Vorrichtung zur besamung von tieren, insbesondere sauen
DE69912422D1 (de) Methode zur behandlung von fruchtbarkeitsstörungen
EP1192952A3 (de) Ein NK-3 rezeptorantagonisten und ein ZNS-penetrierende NK-1 rezeptorantagonisten enthaltende Zusammensetzung zur Behandlung von Depression und Angst
WO2001058409A3 (en) Method of reducing aluminum levels in the central nervous system
HUP0203050A2 (hu) Endometriózis és meddőség kezelésére, valamint a termékenység fokozására alkalmas gyógyszerkészítmények
MXPA05010871A (es) Metodos para administrar estrogenos y progestinas.
AR043013A1 (es) Composicion farmaceutica destinada al tratamiento de la endometriosis
DE602005012054D1 (de) Verwendung von barusiban zur herstellung eines medikaments zur behandlung von hypertonie bei schwangerschaft
ATE491464T1 (de) Lh zur verwendung der erhaltung einer oder mehreren schwangerschaften durch induktion der bildung des sekundären gelbkörpers.
BG105434A (en) Sertraline oral concentrate
EP1260221A3 (de) Kombinationsbehandlung für Depression und Angstzustände
HRP20070271T3 (en) Use of follicle stimulating hormone for reduction of spermatozoa chromosomal aberration in males
KR970061245A (ko) 프로제스테론 및 에스트로젠 작동약을 사용한, 뼈 손실 예방용 약학 조성물
BR0311881A (pt) Combinações de inbidores de pde-v e antagonistas de nk1 para o tratamento de depressão

Legal Events

Date Code Title Description
8364 No opposition during term of opposition